Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Screening for hepatocellular carcinoma.

Tariq Parvez1, Babar Parvez, Khurram Pervaiz

  • 1Department of Oncology, King Fahad Hospital, Al-Madina Al-Munawra, Kingdom of Saudi Arabia. tariq_parvez52@hotmail.com

Journal of the College of Physicians and Surgeons--Pakistan : JCPSP
|September 9, 2004
PubMed
Summary

Liver cancer screening aims for early detection in cirrhosis patients. Screening protocols, using ultrasonography and alpha-fetoprotein, should target individuals who can benefit from available hepatocellular carcinoma treatments.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Lone AF - Etiologic Factors and Genetic Insights into Pathophysiolgy.

Journal of atrial fibrillation·2017
Same author

Evaluation of a Prediction Model for the Development of Atrial Fibrillation in a Repository of Electronic Medical Records.

JAMA cardiology·2016
Same author

Measurement of diffuse ventricular fibrosis with myocardial T1 in patients with atrial fibrillation.

Journal of arrhythmia·2016
Same author

Triceps fascial tongue exposure for total elbow arthroplasty: surgical technique and case series.

Techniques in hand & upper extremity surgery·2015
Same author

Genetic and clinical risk prediction model for postoperative atrial fibrillation.

Circulation. Arrhythmia and electrophysiology·2015
Same author

A common variant on chromosome 4q25 is associated with prolonged PR interval in subjects with and without atrial fibrillation.

The American journal of cardiology·2013

Area of Science:

  • Hepatology
  • Oncology
  • Medical Diagnostics

Background:

  • Liver cancer, specifically hepatocellular carcinoma (HCC), is a leading cause of cancer mortality worldwide.
  • The cure rate for HCC has stagnated over the last two decades, highlighting the need for improved early detection and treatment strategies.
  • Hepatocellular carcinoma predominantly arises in patients with underlying liver cirrhosis, regardless of its cause.

Purpose of the Study:

  • To outline the rationale and methodology for screening programs targeting early detection of hepatocellular carcinoma in at-risk populations.
  • To emphasize the importance of selecting patients with cirrhosis for screening who are candidates for effective treatment.
  • To define the recommended screening modalities and frequency for liver cancer detection.

Main Methods:

Related Experiment Videos

  • Screening programs for patients with cirrhosis are essential for early identification of hepatocellular carcinoma.
  • The decision to screen should be based on the potential benefit from available treatments for diagnosed HCC.
  • Recommended screening involves regular ultrasonography and alpha-fetoprotein level monitoring at 3–6 month intervals.

Main Results:

  • Early detection of hepatocellular carcinoma through screening can lead to more effective treatment outcomes.
  • Ultrasonography and alpha-fetoprotein serve as key diagnostic tools in current HCC screening protocols.
  • Screening frequency should be adapted to community prevalence and economic factors.

Conclusions:

  • Screening programs are crucial for improving outcomes in liver cancer patients with cirrhosis.
  • Targeted screening ensures that diagnostic efforts are focused on individuals likely to benefit from HCC treatment.
  • The implementation of ultrasonography and alpha-fetoprotein testing at regular intervals is vital for effective liver cancer surveillance.